The bias in tumor cell proliferation toward peristromal niches under ALKi therapy was not limited to alectinib treatment, as lorlatinib induced a similar effect in H3122 tumors grafted in regular NSG mice that lacked the functional HGF-cMET axis (Fig. S4A). Here, HGF is linked to neoplasm.